NIH-funded research NIH-funded research

Developing vaccines for dengue and related viruses

Official title: Project 2: Vaccine Design Epidemic Flaviviruses

Funded at Washington University · NIH-10863003 · Data updated 2026-11-12

This study is working on new vaccines to help protect people from dengue virus and similar viruses, using a special method to create proteins that can boost your immune system, so we can better handle current and future outbreaks.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionWashington University
NIH-funded
Lab location1 site (Saint Louis, United States)
Project startAugust 12, 2024
Project endJuly 31, 2027
Funding year2024
Award (this year)$4,782,234
NIH project number1U19AI181960-01
Project IDNIH-10863003 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals living in or traveling to regions where dengue and related flaviviruses are prevalent.

Less likely to help

Patients who are not at risk of exposure to flaviviruses or those who have already been vaccinated against these viruses may not benefit from this research.

What this research studies

This research focuses on creating effective vaccines for flaviviruses, particularly dengue virus type 2, which poses a significant health threat globally. The team aims to utilize a novel structure-based method to produce stable proteins that can trigger strong immune responses. By developing modular vaccine platforms, they hope to provide solutions for current and future outbreaks of dengue and other related viruses. Patients may benefit from these vaccines, which are designed to be adaptable to various flavivirus strains.

Why it matters

Potential benefit: If successful, this research could lead to effective vaccines that significantly reduce the incidence of dengue fever and other flavivirus-related diseases.

How similar studies have gone: Previous research has shown promise in developing vaccines for flaviviruses, indicating that this approach could lead to significant advancements in public health.

Where this research is happening

  • Washington University
    Saint Louis, United States
    Active

Researchers

  • Principal investigator: Desilva, Aravinda M. — Washington University
  • Study coordinator: Desilva, Aravinda M.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.